Open AccessIndian society for study of pain, cancer pain special interest group guidelines on pharmacological management of cancer pain (Part III)
Author(s) -
RaghuS Thota,
Raghavendra Ramanjulu,
Arif Ahmed,
Pranay Jain,
Sushma Bhatnagar,
Naveen Salins,
Aparna Chatterjee,
Dipasri Bhattacharya
Publication year - 2020
Publication title -
indian journal of palliative care/indian journal of palliative care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.395
H-Index - 26
eISSN - 1998-3735
pISSN - 0973-1075
DOI - 10.4103/0973-1075.285694
Subject(s) - medicine , cancer pain , neuropathic pain , palliative care , cancer , quality of life (healthcare) , pain management , population , alternative medicine , physical therapy , intensive care medicine , nursing , anesthesia , environmental health , pathology
The Indian Society for Study of Pain (ISSP), Cancer Pain Special Interest Group, guidelines on pharmacological management of cancer pain in adults provide a structured, step-wise approach which will help to improve the management of cancer pain and to provide patients with a minimally acceptable quality of life. The guidelines have been developed based on the available literature and evidence, to suit the needs, patient population, and situations in India. A questionnaire based on the key elements of each sub draft addressing certain inconclusive areas where evidence was lacking, was made available on the ISSP website and circulated by E-mail to all the ISSP and Indian Association of Palliative Care members. Antidepressants and/or anticonvulsants should be used to treat neuropathic cancer pain and the dose should be titrated according to the clinical response and side effects. External beam radiotherapy should be offered to all patients with painful metastatic bone pain. There is evidence on the use of ketamine in cancer neuropathic pain, but with no beneficial effect, thus it is not recommended.